Wandong Medical has obtained patents related to X-ray equipment, with X-ray detection devices used for vascular interventional X-ray diagnosis.

March 29 news: Information from the State Intellectual Property Office shows that Beijing Wandong Medical Technology Co., Ltd. has filed a patent titled “X-ray Detection Equipment.” The authorized publication number is CN309875224S, and the authorized publication date is March 27, 2026. The application number is CN202530416888.6; the application publication date is March 27, 2026; the application date is July 16, 2025. The inventors are Xia Yuanqiang and Lu Mingyuan. The patent agent is Beijing Huaxia Taihe Intellectual Property Agency Co., Ltd., and the patent agent is Han Laibing. Classification number is 10-05(15).

The patent abstract shows: 1. The name of this design product: X-ray Detection Equipment. 2. The use of this design product: for X-ray photography and diagnostic purposes during vascular interventional surgery. 3. The design key points of this design product: lie in the shape. 4. The pictures or photographs that best show the design key points: Perspective view 1.

Wandong Medical was founded on May 12, 1997, and listed on the Shanghai Stock Exchange on May 19, 1997. Its registered address and office address are both in Beijing. It is a leading domestic enterprise in medical imaging equipment, and its core business covers medical imaging equipment, with advantages across the entire industry chain.

The Shenwan industry classification for Wandong Medical is Pharmaceuticals and Biologics - Medical Devices - Medical Equipment. It involves concept sectors such as AI applications (pharmaceuticals and medical treatment), internet medical care, and medical informatization, and mainly engages in the R&D, manufacturing, sales of imaging medical devices, and imaging diagnostic services.

In 2025, Wandong Medical achieved operating revenue of RMB 1.347 billion. It ranked 3rd among the five companies in the industry, higher than the industry average of RMB 1.192 billion. It was on par with the median, but lower than the 1st-ranked company Haier Biomedical’s RMB 2.329 billion and the 2nd-ranked company Furui Medical’s RMB 1.595 billion.

In terms of its main business composition, revenue from medical device sales was RMB 1.151 billion, accounting for 85.42%; other (supplementary) revenue was RMB 132 million, accounting for 9.79%; labor and services were RMB 64.4624 million, accounting for 4.79%. Regarding net profit, in 2025 it incurred a loss of RMB 228 million, ranking 5th in the industry, far below Furui Medical’s RMB 258 million (1st in the industry) and Haier Biomedical’s RMB 255 million (2nd in the industry). It is also lower than the industry average of RMB 78.9285 million and the median of RMB 89.7758 million.

Wandong Medical Technology Co., Ltd. of Beijing’s recent patent situation is as follows:

Disclaimer: The market involves risk; investment must be done with caution. This article is automatically published by an AI large model based on third-party databases and does not represent Sina Finance’s viewpoints. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there are discrepancies, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

A massive amount of information and precise analysis—right here in the Sina Finance app

责任编辑：小浪快报